Education
About Us
Working with TipRanks
Follow Us
AdaptHealth (AHCO)
NASDAQ:AHCO
AHCO Stock Chart & Stats
$9.68
$0.16(1.59%)
At close: 4:00 PM EST
$9.68
$0.16(1.59%)
Day’s Range― - ―
52-Week Range$7.11 - $11.63
Previous CloseN/A
Volume245.49K
Average Volume (3M)1.00M
Market Cap
$1.34B
Enterprise Value$3.06B
Total Cash (Recent Filing)$80.36M
Total Debt (Recent Filing)$1.90B
Price to Earnings (P/E)18.1
Beta0.59
Next Earnings
Mar 03, 2026EPS Estimate
0.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.24
Shares Outstanding135,424,330
10 Day Avg. Volume860,398
30 Day Avg. Volume1,004,008
Financial Highlights & Ratios
PEG Ratio-0.13
Price to Book (P/B)0.81
Price to Sales (P/S)0.39
P/FCF Ratio5.40
Enterprise Value/Market Cap2.29
Enterprise Value/Revenue1.07
Enterprise Value/Gross Profit8.77
Enterprise Value/Ebitda4.70
Forecast
1Y Price Target
$13.67Price Target Upside41.22% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)0.72
Revenue Forecast (FY)$3.23B
Bulls Say, Bears Say
Bulls Say
Core Business FocusAdapt is focusing on core business areas like Sleep, Respiratory, Diabetes, and Wellness at Home, which is leading to improved financial performance and patient service.
Deleveraging EffortsAdapt's deleveraging efforts are reducing the company's risk profile, which could lead to multiple expansion in the future.
Technology And AI ImplementationThe reorganization and standardization efforts are expected to enable effective implementation of AI and technology, improving margins and insulating profitability.
Bears Say
Earnings PerformanceEPS of $0.11 came in below both the estimate and consensus.
EBITDA ForecastsLowering estimates for 2025-26 EBITDA forecasts, which affects the financial outlook despite maintaining the price target.
Revenue OutlookAdapthealth lowered its 2025 revenue outlook by about 1% at the midpoint.
AdaptHealth News
AHCO FAQ
What was AdaptHealth’s price range in the past 12 months?
AdaptHealth lowest stock price was $7.11 and its highest was $11.63 in the past 12 months.
What is AdaptHealth’s market cap?
AdaptHealth’s market cap is $1.34B.
When is AdaptHealth’s upcoming earnings report date?
AdaptHealth’s upcoming earnings report date is Mar 03, 2026 which is in 96 days.
How were AdaptHealth’s earnings last quarter?
AdaptHealth released its earnings results on Nov 04, 2025. The company reported $0.237 earnings per share for the quarter, missing the consensus estimate of $0.241 by -$0.004.
Is AdaptHealth overvalued?
According to Wall Street analysts AdaptHealth’s price is currently Undervalued.
Does AdaptHealth pay dividends?
AdaptHealth does not currently pay dividends.
What is AdaptHealth’s EPS estimate?
AdaptHealth’s EPS estimate is 0.36.
How many shares outstanding does AdaptHealth have?
AdaptHealth has 135,424,330 shares outstanding.
What happened to AdaptHealth’s price movement after its last earnings report?
AdaptHealth reported an EPS of $0.237 in its last earnings report, missing expectations of $0.241. Following the earnings report the stock price went up 17.382%.
Which hedge fund is a major shareholder of AdaptHealth?
Currently, no hedge funds are holding shares in AHCO
AdaptHealth Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$13.67 (41.22% Upside)
$13.67 (41.22% Upside)
Blogger Sentiment
Bullish
AHCO Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 198.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.2%
Last 30 Days ▲ 5.5%
Last 30 Days ▲ 5.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.05%
12-Months-Change
Fundamentals
Return on Equity
4.77%
Trailing 12-Months
Asset Growth
-1.93%
Trailing 12-Months
Company Description
AdaptHealth
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
AHCO Company Deck
AHCO Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook with strong organic growth, improved profitability, and significant debt reduction. However, there were challenges in the Wellness at Home segment and softer than expected starts in Diabetes Health.View all AHCO earnings summariesAHCO Stock 12 Month Forecast
Average Price Target
$13.67
▲(41.22% Upside)
Technical Analysis
Ufp Technologies
―
LivaNova
―
Senseonics Holdings
―
Establishment Labs Holdings
―
Bioventus
―
Ownership Overview
Currently, No data available
---